Stereotaxis shares surge 14.02% intraday after FDA approves MAGiC magnetic ablation catheter for robotic cardiac ablation.

Stereotaxis surged 14.02% intraday, as the company announced that its MAGiC magnetic interventional ablation catheter received FDA approval for robotic navigation in cardiac ablation procedures for complex arrhythmia patients. Stereotaxis, a pioneer and global leader in surgical robotics, specializes in designing, manufacturing, and selling robotic systems for minimally invasive endovascular interventions, with its technology used in over 150,000 cardiac electrophysiology procedures globally.